PUBLICATIONS

Inomagen Awarded $3.67 million NIH SBIR Fast Track Grant to Develop Gene Therapy for Atrial Fibrillation Identified major molecular mechanisms that contribute to AF in a majority of patients with Atrial Fibrillation

Attenuation of Oxidative Injury With Targeted Expression of NADPH Oxidase 2 Short Hairpin RNA Prevents Onset and Maintenance of Electrical Remodeling in the Canine Atrium

A Novel Gene Therapy Approach to Atrial Fibrillation

Gene therapy for atrial fibrillation - How close to clinical implementation?

Amar Trivedi, Jacob Hoffman, Rishi Arora *Feinberg Cardiovascular and Renal Research Institute, Northwestern University e Feinberg School of Medicine, United States of America